Benjamin J. Hindson - Feb 22, 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Feb 22, 2022
Transactions value $
-$28,294
Form type
4
Date filed
2/24/2022, 06:40 PM
Previous filing
Jan 5, 2022
Next filing
Mar 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$28.3K -360 -0.22% $78.59 160K Feb 22, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Class B Common Stock Gift $0 -267K -8.9% $0.00 2.73M Feb 22, 2022 Class A Common Stock 267K See footnote F2, F3
transaction TXG Class B Common Stock Gift $0 +134K $0.00 134K Feb 22, 2022 Class A Common Stock 134K See footnote F2, F4
transaction TXG Class B Common Stock Gift $0 +134K $0.00 134K Feb 22, 2022 Class A Common Stock 134K See footnote F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation.
F3 Shares held by Hindson Family Revocable Trust DTD 11/04/2014.
F4 Shares held by Irrevocable Hindson Descendants' Trust FBO BAH DTD 12/15/2021.
F5 Shares held by Irrevocable Hindson Descendants' Trust FBO BLH DTD 12/15/2021.

Remarks:

Chief Scientific Officer and President